Aspirin 75mg + Clopidogrel 75mg
Aspirin irreversibly blocks COX-1 to prevent thromboxane A2-mediated platelet aggregation. Clopidogrel blocks ADP-mediated platelet activation through P2Y12 receptor antagonism. Dual antiplatelet therapy provides more effective clot prevention than either agent alone.
Post-ACS, post-stenting, TIA/stroke prevention, peripheral arterial disease, high clotting risk.
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
STENFLOW AS 75 provides the guideline-recommended dual antiplatelet combination for post-ACS and post-stenting patients — reducing clot risk through two complementary mechanisms in one affordable capsule.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.